|
| 35948282 | A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics. | Neuro Oncol | 2023 |
| 37188783 | Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. | Nat Med | 2023 |
| 35344029 | Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study. | Clin Cancer Res | 2022 |
| 34056607 | Bintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-β and PD-L1: results from a phase I expansion cohort in patients with recurrent glioblastoma. | Neurooncol Adv | 2021 |
| 32166308 | A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma. | Neuro Oncol | 2020 |
| 32506369 | Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer. | J Neurooncol | 2020 |
| 30359477 | Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma. | Cancer | 2019 |
| 30707757 | Reply to Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma. | Cancer | 2019 |
| 31148247 | Differentiation of 2-hydroxyglutarate enantiomers and its lactones by gas chromatography/electron ionization tandem mass spectrometry. | Rapid Commun Mass Spectrom | 2019 |
| 30668804 | Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications. | Neuro Oncol | 2019 |
| 28039364 | Leptomeningeal metastases: a RANO proposal for response criteria. | Neuro Oncol | 2017 |
| 28215459 | Leptomeningeal metastases presenting exclusively with ocular disturbance in 34 patients: A tertiary care cancer hospital experience. | J Clin Neurosci | 2017 |
| 28802798 | Most common sites on MRI of intracranial neoplastic leptomeningeal disease. | J Clin Neurosci | 2017 |
| 26476729 | A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients. | J Neurooncol | 2016 |
| 25239666 | Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma. | Neuro Oncol | 2015 |
| 25586468 | A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study. | Neuro Oncol | 2015 |
| 24470557 | Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02. | Neuro Oncol | 2014 |
| 24867803 | Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials. | Neuro Oncol | 2014 |
| 23349317 | Phase I study of GRN1005 in recurrent malignant glioma. | Clin Cancer Res | 2013 |
| 23633392 | Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma. | Cancer | 2013 |
| 23761024 | Bevacizumab use in disseminated choroid plexus papilloma. | J Neurooncol | 2013 |
| 23756727 | Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis. | J Neurooncol | 2013 |
| 23576814 | The identification and characterization of breast cancer CTCs competent for brain metastasis. | Sci Transl Med | 2013 |
| 23292836 | Leptomeningeal metastases from genitourinary cancer: the University of Texas MD Anderson Cancer Center experience. | Med Oncol | 2013 |
| 23363814 | A phase I/II trial of pazopanib in combination with lapatinib in adult patients with relapsed malignant glioma. | Clin Cancer Res | 2013 |
| 21964738 | A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. | J Neurooncol | 2012 |
| 25031951 | Intraventricular topotecan for the treatment of neoplastic meningitis: five case studies. | J Adv Pract Oncol | 2012 |
| 22810137 | Helping patients make the best decision regarding duration of temozolomide chemotherapy treatment. | Continuum (Minneap Minn) | 2012 |
| 22547604 | Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors. | J Clin Oncol | 2012 |
| 22086614 | Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma. | Cancer | 2012 |
| 20652724 | Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma. | J Neurooncol | 2011 |
| 21499746 | High-grade gliomas. | Curr Treat Options Neurol | 2011 |
| 21109151 | Leptomeningeal disease. | Neurosurg Clin N Am | 2011 |
| 20425607 | Biology and therapy of neoplastic meningitis. | Curr Oncol Rep | 2010 |
| 20729242 | A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma. | Neuro Oncol | 2010 |
| 20440539 | Tonsillar pseudotumor: complications of chronically-administered temozolomide. | J Neurooncol | 2010 |
| 20212228 | New strategies in the management of leptomeningeal metastases. | Arch Neurol | 2010 |
| 20146587 | Known and emerging biomarkers of leptomeningeal metastasis and its response to treatment. | Future Oncol | 2010 |
| 19197219 | Comparative risk of leptomeningeal dissemination of cancer after surgery or stereotactic radiosurgery for a single supratentorial solid tumor metastasis. | Neurosurgery | 2009 |
| 19660682 | Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment. | Semin Oncol | 2009 |
| 19672263 | Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme. | Br J Cancer | 2009 |
| 19267183 | Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma. | J Neurooncol | 2009 |
| 18398571 | Low grade astrocytoma presenting with visual loss. | J Neurooncol | 2008 |
| 18581057 | Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma. | J Neurooncol | 2008 |
| 18708343 | Prognostic factors and outcomes in patients with leptomeningeal melanomatosis. | Neuro Oncol | 2008 |
| 18316473 | A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies. | Neuro Oncol | 2008 |
| 18314417 | Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme. | Neuro Oncol | 2008 |
| 18240919 | Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa. | J Neurosurg | 2008 |
| 17031561 | A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme. | J Neurooncol | 2007 |
| 17269713 | Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients. | J Proteome Res | 2007 |